Liquidia Corp (LQDA)
13.29
-0.52
(-3.77%)
USD |
NASDAQ |
Apr 19, 16:00
13.29
0.00 (0.00%)
After-Hours: 20:00
Liquidia Gross Profit Margin (Quarterly): 78.08% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 78.08% |
| September 30, 2023 | 84.50% |
| June 30, 2023 | 85.98% |
| March 31, 2023 | 85.44% |
| December 31, 2022 | 87.05% |
| September 30, 2022 | 76.62% |
| June 30, 2022 | 81.34% |
| March 31, 2022 | 80.13% |
| December 31, 2021 | 77.42% |
| September 30, 2021 | 72.00% |
| June 30, 2021 | 78.85% |
| March 31, 2021 | 77.50% |
| December 31, 2020 | 67.86% |
| September 30, 2020 |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | 90.00% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | 90.95% |
| March 31, 2018 | 97.08% |
| December 31, 2017 | 95.60% |
| September 30, 2017 | 95.61% |
| June 30, 2017 | 95.97% |
| March 31, 2017 | 95.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.86%
Minimum
Dec 2020
90.00%
Maximum
Jun 2019
80.20%
Average
79.49%
Median
Gross Profit Margin (Quarterly) Benchmarks
| United Therapeutics Corp | 88.45% |
| AIM ImmunoTech Inc | 81.54% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 15.54% |
| Armata Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -119.7% |
| Return on Assets | -64.38% |
| Return on Invested Capital | -112.8% |
| Profit Margin (Quarterly) | -605.8% |
| Operating Margin (Quarterly) | -583.4% |
| Return on Net Operating Assets | -440.6% |